Chinese electric vehicle manufacturer XPeng Inc intends to sell 85 million American depositary shares (ADS) to raise up to $1.11 billion in its initial public offering (IPO) in New York.
Each ADS represents two Class A ordinary shares, priced between $11 and $13.
According to XPeng, existing investors Alibaba Group, Coatue, and Qatar Investment Authority had expressed interest in buying the ADSs of up to $200 million, $100 million and $50 million, respectively.
Xiaomi Corp also indicated an interest in purchasing up to $50 million of the ADSs.
US-listed Chinese companies are under tightened scrutiny and facing strict audit requirements from US regulators.
Alibaba is set to acquire all of XPeng’s class C ordinary shares, representing 14.9 percent of the voting power of all shares.
Another Chinese electric vehicle startup, Li Auto Inc LI.O, was able to raise $1.09 billion in its Nasdaq IPO last month.
The valuation of Guangzhou-based XPeng stood at $9.17 billion.
Founded in 2014, XPeng manufactures cars in two factories in China.


Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 



